GPER1 and breast cancer: Considering the recent evidence indicating that TAM can activate non-genomic GPER/ERK signaling and enhance breast cancer cell growth, inhibition of ER/GPER/ERK signaling could provide a new therapeutic option for TAM-resistant breast cancer cells.